FDA Inspection 836582 — Orion Corporation, Orion Pharma

Orion Corporation, Orion Pharma — FEI 3003743938

The FDA completed an inspection of Orion Corporation, Orion Pharma on May 24, 2013 in Turku. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Turku (Finland)